Minerva Neurosciences, Inc. - Common Stock, par value $0.0001 per share (NERV)

23 filings reported holding NERV - Minerva Neurosciences, Inc. - Common Stock, par value $0.0001 per share as of Q4 2024.
Minerva Neurosciences, Inc. - Common Stock, par value $0.0001 per share (NERV) has 21 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 2,085,897 shares of 86,001,722 outstanding shares and own 2.4% of the company stock.
Largest 10 shareholders include FEDERATED HERMES, INC. (1,351,275 shares), VANGUARD GROUP INC (252,060 shares), RENAISSANCE TECHNOLOGIES LLC (128,100 shares), OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) (107,256 shares), BlackRock, Inc. (72,669 shares), GEODE CAPITAL MANAGEMENT, LLC (56,456 shares), NORTHERN TRUST CORP (36,878 shares), CITADEL ADVISORS LLC (25,764 shares), ACADIAN ASSET MANAGEMENT LLC (17,416 shares), and STATE STREET CORP (16,519 shares).
This table shows the top 21 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.